Relative Bioavailability and Food Effect Study of CVN424
NCT05635461
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson's Disease
Interventions
DRUG:
CVN424
Sponsor
Cerevance Beta, Inc.